Heart transplant recipient and T2 Biosystems President and CEO John Sperzel is passionate about pioneering advancements in life-saving technologies. He has spent decades in the healthcare diagnostics industry and hopes to one day solve the crisis of sepsis, which claims eleven million lives each year.